Self-medication of a cannabinoid CB 2 agonist in an animal model of neuropathic pain

Pain

Volumn 152, Issue 9, 2011, Pages 1976-1987

  Gutierrez, Tannia ^a,b   Crystal, Jonathon D ^a,b   Zvonok, Alexander M ^c   Makriyannis, Alexandros ^c   Hohmann, Andrea G ^a,b  

^a University of Georgia ^*  (United States)

^b INDIANA UNIVERSITY   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Allodynia; Analgesic; Dependence; Drug abuse; Drug self administration; Hyperalgesia

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOCKING FACTOR; CONTROLLED STUDY; DRUG EFFECT; MALE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SELF MEDICATION;

ANIMALS; CANNABINOIDS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; SELF MEDICATION;

EID: 80051798808     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2011.03.038     Document Type: Article

References (58)

1. S.H. Ahmed, and G.F. Koob Cocaine- but not food-seeking behavior is reinstated by stress after extinction Psychopharmacology (Berl) 132 1997 289 295 (Pubitemid 27351430)
2. J.C. Ballantyne, and N.S. Shin Efficacy of opioids for chronic pain: a review of the evidence Clin J Pain 24 2008 469 478
3. R. Baron Neuropathic pain: a clinical perspective Handb Exp Pharmacol 194 2009 3 30
4. M. Beltramo, N. Bernardini, R. Bertorelli, M. Campanella, E. Nicolussi, S. Fredduzzi, and A. Reggiani CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms Eur J Neurosci 23 2006 1530 1538
5. R. Benyamin, A.M. Trescot, S. Datta, R. Buenaventura, R. Adlaka, N. Sehgal, S.E. Glaser, and R. Vallejo Opioid complications and side effects Pain Physician 11 2008 S105 S120
6. D. Bridges, K. Ahmad, and A.S. Rice The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain Br J Pharmacol 133 2001 586 594 (Pubitemid 32591925)
7. N.E. Buckley, K.L. McCoy, E. Mezey, T. Bonner, A. Zimmer, C.C. Felder, and M. Glass Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor Eur J Pharmacol 396 2000 141 149 (Pubitemid 30265571)
8. N. Clayton, F.H. Marshall, C. Bountra, and C.T. O'Shaughnessy CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain Pain 96 2002 253 260 (Pubitemid 34327871)
9. F.C. Colpaert, T. Meert, P. De Witte, and P. Schmitt Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat Life Sci 31 1982 67 75 (Pubitemid 12046640)
10. F.C. Colpaert, J.P. Tarayre, M. Alliaga, L.A. Bruins Slot, N. Attal, and W. Koek Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats Pain 91 2001 33 45 (Pubitemid 32274173)
11. I. Decosterd, and C.J. Woolf Spared nerve injury: an animal model of persistent peripheral neuropathic pain Pain 87 2000 149 158 (Pubitemid 30621447)
12. S.J. Elmes, M.D. Jhaveri, D. Smart, D.A. Kendall, and V. Chapman Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain Eur J Neurosci 20 2004 2311 2320 (Pubitemid 39472394)
13. A. Fox, A. Kesingland, C. Gentry, K. McNair, S. Patel, L. Urban, and I. James The role of central and peripheral cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain Pain 92 2001 91 100 (Pubitemid 32367940)
14. L.R. Gardell, T. King, M.H. Ossipov, K.C. Rice, J. Lai, T.W. Vanderah, and F. Porreca Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery Neurosci Lett 396 2006 44 49 (Pubitemid 43233785)
15. E.L. Gardner Addictive potential of cannabinoids: the underlying neurobiology Chem Phys Lipids 121 2002 267 290 (Pubitemid 36044556)
16. E.L. Gardner Endocannabinoid signaling system and brain reward: emphasis on dopamine Pharmacol Biochem Behav 81 2005 263 284 (Pubitemid 40807127)
17. S.W. Greenhouse, and S. Geisser On methods in the analysis of profile data Psychometrika 24 1959 95 112
18. A.V. Guerrero, P. Quang, N. Dekker, R.C. Jordan, and B.L. Schmidt Peripheral cannabinoids attenuate carcinoma-induced nociception in mice Neurosci Lett 433 2008 77 81
19. J. Guindon, and A.G. Hohmann Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain Br J Pharmacol 153 2008 319 334
20. J. Guindon, J.S. Walczak, and P. Beaulieu Recent advances in the pharmacological management of pain Drugs 67 2007 2121 2133 (Pubitemid 47557090)
21. T. Gutierrez, J.N. Farthing, A.M. Zvonok, A. Makriyannis, and A.G. Hohmann Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis Br J Pharmacol 150 2007 153 163 (Pubitemid 46160605)
22. L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, M. Horowitz, R.G. Pertwee, R.A. Ross, R. Mechoulam, and E. Fride HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor Proc Natl Acad Sci USA 96 1999 14228 14233 (Pubitemid 30000633)
23. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 11 1991 563 583
24. U. Herzberg, E. Eliav, G.J. Bennett, and I.J. Kopin The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neurosci Lett 221 1997 157 160 (Pubitemid 27049222)
25. A.G. Hohmann, J.N. Farthing, A.M. Zvonok, and A. Makriyannis Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin J Pharmacol Exp Ther 308 2004 446 453 (Pubitemid 38134203)
26. G.C. Hsieh, M. Pai, P. Chandran, B.A. Hooker, C.Z. Zhu, A.K. Salyers, E.J. Wensink, C. Zhan, W.A. Carroll, M.J. Dart, B.B. Yao, P. Honore, and M.D. Meyer Central and peripheral sites of action for CB(2) receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats Br J Pharmacol 162 2011 428 440
27. M.M. Ibrahim, H. Deng, A. Zvonok, D.A. Cockayne, J. Kwan, H.P. Mata, T.W. Vanderah, J. Lai, F. Porreca, A. Makriyannis, and T.P. Malan Jr Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS Proc Natl Acad Sci USA 100 2003 10529 10533 (Pubitemid 37071912)
28. M.M. Ibrahim, F. Porreca, J. Lai, P.J. Albrecht, F.L. Rice, A. Khodorova, G. Davar, A. Makriyannis, T.W. Vanderah, H.P. Mata, and T.P. Malan Jr. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids Proc Natl Acad Sci USA 102 2005 3093 3098 (Pubitemid 40299921)
29. M.D. Jhaveri, S.J. Elmes, D. Richardson, D.A. Barrett, D.A. Kendall, R. Mason, and V. Chapman Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats Eur J Neurosci 27 2008 1722 1730 (Pubitemid 351473595)
30. T. King, L. Vera-Portocarrero, T. Gutierrez, T.W. Vanderah, G. Dussor, J. Lai, H.L. Fields, and F. Porreca Unmasking the tonic-aversive state in neuropathic pain Nat Neurosci 12 2009 1364 1366
31. C.J. LaBuda, M. Koblish, and P.J. Little Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain Eur J Pharmacol 527 2005 172 174 (Pubitemid 41745165)
32. B. Lian, L. Vera-Portocarrero, T. King, M.H. Ossipov, and F. Porreca Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity Brain Res 1358 2010 64 70
33. Q.R. Liu, C.H. Pan, A. Hishimoto, C.Y. Li, Z.X. Xi, A. Llorente-Berzal, M.P. Viveros, H. Ishiguro, T. Arinami, E.S. Onaivi, and G.R. Uhl Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands Genes Brain Behav 8 2009 519 530
34. A.N. Lozano-Ondoua, C. Wright, A. Vardanyan, T. King, T.M. Largent-Milnes, M. Nelson, J.M. Jimenez-Andrade, P.W. Mantyh, and T.W. Vanderah A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss Life Sci 86 2010 646 653
35. W.H. Lyness, F.L. Smith, J.E. Heavner, C.U. Iacono, and R.D. Garvin Morphine self-administration in the rat during adjuvant-induced arthritis Life Sci 45 1989 2217 2224 (Pubitemid 20003066)
36. T.P. Malan Jr., M.M. Ibrahim, H. Deng, Q. Liu, H.P. Mata, T. Vanderah, F. Porreca, and A. Makriyannis CB2 cannabinoid receptor-mediated peripheral antinociception Pain 93 2001 239 245 (Pubitemid 32763181)
37. R. Maldonado Study of cannabinoid dependence in animals Pharmacol Ther 95 2002 153 164 (Pubitemid 35232133)
38. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, R.K. Razdan, M.R. Johnson, L.S. Melvin, R. Mechoulam, and S.J. Ward Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol Biochem Behav 40 1991 471 478
39. T.J. Martin, S.A. Kim, N.L. Buechler, F. Porreca, and J.C. Eisenach Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics Anesthesiology 106 2007 312 322 (Pubitemid 46185177)
40. T.J. Martin, S.A. Kim, D.G. Cannon, G.M. Sizemore, D. Bian, F. Porreca, and J.E. Smith Antagonism of delta(2)-opioid receptors by naltrindole-5′- isothiocyanate attenuates heroin self-administration but not antinociception in rats J Pharmacol Exp Ther 294 2000 975 982 (Pubitemid 30666849)
41. A.G. Nackley, A. Makriyannis, and A.G. Hohmann Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation Neuroscience 119 2003 747 757 (Pubitemid 36694801)
42. A.G. Nackley, A.M. Zvonok, A. Makriyannis, and A.G. Hohmann Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation J Neurophysiol 92 2004 3562 3574 (Pubitemid 39506332)
43. E.S. Onaivi An endocannabinoid hypothesis of drug reward and drug addiction Ann NY Acad Sci 1139 2008 412 421
44. A. Quartilho, H.P. Mata, M.M. Ibrahim, T.W. Vanderah, F. Porreca, A. Makriyannis, and T.P. Malan Jr. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors Anesthesiology 99 2003 955 960 (Pubitemid 37186088)
45. E.J. Rahn, A. Makriyannis, and A.G. Hohmann Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats Br J Pharmacol 152 2007 765 777 (Pubitemid 350041538)
46. E.J. Rahn, A.M. Zvonok, A. Makriyannis, and A.G. Hohmann Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation AAPS J 12 2010 147 157
47. D.R. Sagar, S. Kelly, P.J. Millns, C.T. O'Shaughnessey, D.A. Kendall, and V. Chapman Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats Eur J Neurosci 22 2005 371 379 (Pubitemid 41097610)
48. U. Shalev, J.W. Grimm, and Y. Shaham Neurobiology of relapse to heroin and cocaine seeking: a review Pharmacol Rev 54 2002 1 42 (Pubitemid 34208828)
49. K.J. Sufka Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain Pain 58 1994 355 366 (Pubitemid 24284078)
50. K.J. Sufka, and J.T. Roach Stimulus properties and antinociceptive effects of selective bradykinin B1 and B2 receptor antagonists in rats Pain 66 1996 99 103 (Pubitemid 26247029)
51. C. Toth, and S. Au A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy Pain 138 2008 657 666
52. M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N. Stella, A. Makriyannis, D. Piomelli, J.S. Davison, L.J. Marnett, V. Di Marzo, Q.J. Pittman, K.D. Patel, and K.A. Sharkey Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 2005 329 332 (Pubitemid 41457202)
53. R. Weissenborn, M. Yackey, G.F. Koob, and F. Weiss Measures of cocaine-seeking behavior using a multiple schedule of food and drug self-administration in rats Drug Alcohol Depend 38 1995 237 246
54. G.T. Whiteside, G.P. Lee, and K.J. Valenzano The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists Curr Med Chem 14 2007 917 936 (Pubitemid 46863619)
55. G. Wotherspoon, A. Fox, P. McIntyre, S. Colley, S. Bevan, and J. Winter Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons Neuroscience 135 2005 235 245 (Pubitemid 41219752)
56. J. Zhang, C. Hoffert, H.K. Vu, T. Groblewski, S. Ahmad, and D. O'Donnell Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models Eur J Neurosci 17 2003 2750 2754 (Pubitemid 36819300)
57. A. Zimmer, A.M. Zimmer, A.G. Hohmann, M. Herkenham, and T.I. Bonner Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice Proc Natl Acad Sci USA 96 1999 5780 5785 (Pubitemid 29234695)
58. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110 (Pubitemid 13058546)